Get the Stockscreener App
34.29
2.24%
0.75
Pre-market:
33.52
-0.77
-2.25%
Harmony Biosciences Holdings Inc stock is traded at $34.29, with a volume of 759.86K.
It is up +2.24% in the last 24 hours and up +30.08% over the past month.
Harmony Biosciences Holdings Inc is a commercial-stage pharmaceutical company focused on developing and commercializing therapies for patients living with rare neurological diseases who have unmet medical needs. The company's product WAKIX (pitolisant) is a molecule with a novel mechanism of action specifically designed to increase histamine signaling in the brain by binding to H3 receptors and is used for the treatment of cataplexy in adult patients with narcolepsy. The other drug candidates in its pipeline are Pitolisant, HBS-102 (MCHR1 antagonist), BP1.15205 (orexin-2 receptor agonist), ZYN002 (cannabidiol gel), EPX-100 (clemizole hydrochloride), and EPX-200 (lorcaserin), among others.
See More
Previous Close:
$33.54
Open:
$33.88
24h Volume:
759.86K
Relative Volume:
0.88
Market Cap:
$1.97B
Revenue:
$772.53M
Net Income/Loss:
$180.90M
P/E Ratio:
11.05
EPS:
3.1024
Net Cash Flow:
$258.73M
1W Performance:
+10.83%
1M Performance:
+30.08%
6M Performance:
-0.23%
1Y Performance:
+1.33%
1-Day Range:
$33.73
$34.35
1-Week Range:
$30.55
$34.35
52-Week Range:
$25.52
$40.93
Harmony Biosciences Holdings Inc Stock (HRMY) Company Profile
Name
Harmony Biosciences Holdings Inc
Sector
Industry
Phone
(484) 539-9800
Address
630 W GERMANTOWN PIKE, PLYMOUTH MEETING
Compare HRMY with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
HRMY
Harmony Biosciences Holdings Inc
|
34.29 | 1.93B | 772.53M | 180.90M | 258.73M | 3.1024 |
|
VRTX
Vertex Pharmaceuticals Inc
|
434.52 | 110.16B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
694.99 | 71.65B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
453.97 | 59.81B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
891.73 | 54.79B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
368.36 | 41.77B | 4.98B | 69.59M | 525.67M | 0.5197 |
Harmony Biosciences Holdings Inc Stock (HRMY) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-21-25 | Initiated | Truist | Buy |
| Jul-10-25 | Resumed | Goldman | Neutral |
| Jun-02-25 | Resumed | Oppenheimer | Outperform |
| Feb-11-25 | Initiated | Deutsche Bank | Buy |
| Dec-17-24 | Initiated | H.C. Wainwright | Buy |
| Oct-10-24 | Resumed | Raymond James | Outperform |
| Sep-10-24 | Initiated | UBS | Buy |
| Jun-21-24 | Initiated | Citigroup | Buy |
| Jan-02-24 | Downgrade | BofA Securities | Neutral → Underperform |
| Sep-25-23 | Downgrade | Goldman | Neutral → Sell |
| Sep-07-23 | Initiated | Berenberg | Buy |
| Apr-20-23 | Initiated | BofA Securities | Neutral |
| Oct-14-22 | Upgrade | Janney | Neutral → Buy |
| Oct-14-22 | Upgrade | Jefferies | Hold → Buy |
| Aug-03-22 | Downgrade | Jefferies | Buy → Hold |
| Jul-13-22 | Downgrade | Goldman | Buy → Neutral |
| Jul-07-22 | Initiated | Mizuho | Buy |
| Apr-14-22 | Initiated | Cantor Fitzgerald | Overweight |
| Dec-01-21 | Initiated | Oppenheimer | Outperform |
| Nov-04-21 | Initiated | Raymond James | Outperform |
| Sep-23-21 | Initiated | Needham | Buy |
| Mar-29-21 | Upgrade | Goldman | Neutral → Buy |
| Sep-14-20 | Initiated | Goldman | Neutral |
| Sep-14-20 | Initiated | Jefferies | Buy |
| Sep-14-20 | Initiated | Piper Sandler | Overweight |
View All
Harmony Biosciences Holdings Inc Stock (HRMY) Latest News
Will Harmony Biosciences Holdings Inc. outperform the marketMarket Risk Analysis & Long-Term Safe Investment Plans - newser.com
What technical signals suggest for Harmony Biosciences Holdings Inc. stockTrade Analysis Summary & Free High Return Stock Watch Alerts - newser.com
Forecasting Harmony Biosciences Holdings Inc. price range with options dataWeekly Trade Summary & Stepwise Entry and Exit Trade Signals - newser.com
Using Ichimoku Cloud for Harmony Biosciences Holdings Inc. technicalsWeekly Trend Summary & Free Expert Approved Momentum Trade Ideas - newser.com
Deutsche Bank Raises Price Target on Harmony Biosciences to $47 From $36, Keeps Buy Rating - MarketScreener
Why Harmony Biosciences Holdings Inc. stock could benefit from AI revolutionEarnings Overview Report & AI Powered Trade Plan Recommendations - newser.com
How interest rate cuts could boost Harmony Biosciences Holdings Inc. stock2025 Short Interest & Real-Time Volume Trigger Notifications - newser.com
Using Python tools to backtest Harmony Biosciences Holdings Inc. strategiesWeekly Trend Recap & Verified Stock Trade Ideas - newser.com
Will Harmony Biosciences Holdings Inc. stock reach all time highs in 2025 - newser.com
Sector ETF performance correlation with Harmony Biosciences Holdings Inc.Analyst Downgrade & Community Consensus Stock Picks - newser.com
Harmony Biosciences raises 2025 revenue outlook to $845M-$865M amid record WAKIX patient growth and advancing pipeline - MSN
Harmony Biosciences Holdings, Inc. Q3 2025 Earnings Preview - MSN
(HRMY) Movement as an Input in Quant Signal Sets - news.stocktradersdaily.com
Mizuho Raises Price Target for HRMY, Maintains Outperform Rating - GuruFocus
Will Harmony Biosciences Holdings Inc. stock gain from lower inflationWeekly Gains Summary & High Win Rate Trade Alerts - newser.com
Harmony Biosciences Reports Strong Q3 2025 Results - MSN
Should you hold or exit Harmony Biosciences Holdings Inc. nowJuly 2025 Opening Moves & Scalable Portfolio Growth Ideas - newser.com
Why Harmony Biosciences Holdings Inc. stock is favored by top institutions2025 Year in Review & Smart Money Movement Tracker - newser.com
What insider trading reveals about Harmony Biosciences Holdings Inc. stockTrade Risk Summary & Weekly High Potential Stock Alerts - newser.com
What Wall Street predicts for Harmony Biosciences Holdings Inc. stock priceMarket Trend Review & Technical Analysis for Trade Confirmation - newser.com
Is Harmony Biosciences Holdings Inc. stock a top momentum playEarnings Miss & Community Verified Trade Signals - newser.com
Harmony Biosciences Holdings, I (HRMY) Stock forecasts - Yahoo Finance UK
Harmony Biosciences Holdings, I (HRMY) Stock Forecasts - Yahoo! Finance Canada
Developing predictive dashboards with Harmony Biosciences Holdings Inc. data2025 Institutional Moves & Community Verified Swing Trade Signals - newser.com
How Harmony Biosciences Holdings Inc. stock benefits from strong dollarOptions Play & Advanced Swing Trade Entry Alerts - fcp.pa.gov.br
Raised Revenue Guidance and Strong Q3 Results Could Be a Game Changer for Harmony Biosciences (HRMY) - Yahoo Finance
Harmony Biosciences Holdings, Inc. 2025 Q3ResultsEarnings Call Presentation (NASDAQ:HRMY) 2025-11-05 - Seeking Alpha
Harmony Biosciences Q3 Earnings Call Highlights Robust Growth - MSN
Harmony Biosciences (HRMY) Margin Expansion Reinforces Bullish Value Narrative - Yahoo Finance
Harmony Biosciences Holdings Inc (HRMY) Q3 2025 Earnings Call Highlights: Strong Revenue Growth ... - Investing.com Canada
Harmony Biosciences Holdings Inc Stock (HRMY) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.35%
0.75%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):